[1]

Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Medicine 15:1016−1022

doi: 10.1038/nm.2015
[2]

Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, et al. 2015. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clinical Infectious Diseases 60:208−215

doi: 10.1093/cid/ciu787
[3]

Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, et al. 2017. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS One 12:e0171602

doi: 10.1371/journal.pone.0171602
[4]

Wu S, Lim KC, Huang J, Saidi RF, Sears CL. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proceedings of the National Academy of Sciences of the United States of America 95:14979−14984

doi: 10.1073/pnas.95.25.14979
[5]

Chung L, Thiele Orberg E, Geis AL, Chan JL, Fu K, et al. 2018. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host & Microbe 23: 203−214.e5

doi: 10.1016/j.chom.2018.01.007
[6]

Sears CL. 2009. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clinical Microbiology Reviews 22:349−369

doi: 10.1128/CMR.00053-08
[7]

Wu S, Shin J, Zhang G, Cohen M, Franco A, et al. 2006. The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infection and Immunity 74:5382−5390

doi: 10.1128/IAI.00060-06
[8]

White MT, Wang K, Zhang H, Eckhard U, Hullahalli K, et al. 2026. A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin. Nature 654:504−512

doi: 10.1038/s41586-026-10375-0
[9]

Luo J, Yang Q, Zhang X, Zhang Y, Wan L, et al. 2022. TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile. Cell 185:980−994.e15

doi: 10.1016/j.cell.2022.02.010
[10]

Tao L, Zhang J, Meraner P, Tovaglieri A, Wu X, et al. 2016. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538:350−355

doi: 10.1038/nature19799
[11]

Shrestha A, Uzal FA, McClane BA. 2016. The interaction of Clostridium perfringens enterotoxin with receptor claudins. Anaerobe 41:18−26

doi: 10.1016/j.anaerobe.2016.04.011
[12]

Vecchio AJ, Rathnayake SS, Stroud RM. 2021. Structural basis for Clostridium perfringens enterotoxin targeting of claudins at tight junctions in mammalian gut. Proceedings of the National Academy of Sciences of the United States of America 118:e2024651118

doi: 10.1073/pnas.2024651118
[13]

Cox KE, Liu S, Hoffman RM, Batra SK, Dhawan P, et al. 2024. The expression of the claudin family of proteins in colorectal cancer. Biomolecules 14:272

doi: 10.3390/biom14030272
[14]

Goulas T, Arolas JL, Gomis-Rüth FX. 2011. Structure, function and latency regulation of a bacterial enterotoxin potentially derived from a mammalian adamalysin/ADAM xenolog. Proceedings of the National Academy of Sciences of the United States of America 108:1856−1861

doi: 10.1073/pnas.1012173108
[15]

Abramson J, Adler J, Dunger J, Evans R, Green T, et al. 2024. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630:493−500

doi: 10.1038/s41586-024-07487-w
[16]

Lipper CH, Egan ED, Gabriel KH, Blacklow SC. 2023. Structural basis for membrane-proximal proteolysis of substrates by ADAM10. Cell 186: 3632−3641.e10

doi: 10.1016/j.cell.2023.06.026
[17]

Shah MA, Shitara K, Ajani JA, Bang YJ, Enzinger P, et al. 2023. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nature Medicine 29: 2133−2141

doi: 10.1038/s41591-023-02465-7
[18]

Gorwitz GL, DeRemer DL. 2025. Zolbetuximab-clzb: targeting claudin 18.2 in advanced gastric and gastroesophageal adenocarcinoma. Annals of Pharmacotherapy 59:1119−1127

doi: 10.1177/10600280251342801
[19]

Hill CA, Casterline BW, Valguarnera E, Hecht AL, Shepherd ES, et al. 2024. Bacteroides fragilis toxin expression enables lamina propria niche acquisition in the developing mouse gut. Nature Microbiology 9:85−94

doi: 10.1038/s41564-023-01559-9
[20]

Parida S, Wu S, Siddharth S, Wang G, Muniraj N, et al. 2021. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and β-catenin axes. Cancer Discovery 11:1138−1157

doi: 10.1158/2159-8290.CD-20-0537
[21]

Scott N, Whittle E, Jeraldo P, Chia N. 2022. A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer. Neoplasia 29:100797

doi: 10.1016/j.neo.2022.100797
[22]

Haghi F, Goli E, Mirzaei B, Zeighami H. 2019. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer 19:879

doi: 10.1186/s12885-019-6115-1
[23]

Xia S, Ma L, Li H, Li Y, Yu L. 2025. Prevalence of enterotoxigenic Bacteroides fragilis in patients with colorectal cancer: a systematic review and meta-analysis. Frontiers in Cellular and Infection Microbiology 15:1525609

doi: 10.3389/fcimb.2025.1525609